Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Yong-Gao Mou"'
Autor:
Xiao-Dong Dong, Yan Li, Ying Li, Cong Sun, Shang-Xin Liu, Hao Duan, Run Cui, Qian Zhong, Yong-Gao Mou, Le Wen, Bo Yang, Mu-Sheng Zeng, Min-Hua Luo, Hua Zhang
Publikováno v:
PLoS Pathogens, Vol 19, Iss 5, p e1011304 (2023)
Human cytomegalovirus (HCMV) infection is associated with human glioblastoma, the most common and aggressive primary brain tumor, but the underlying infection mechanism has not been fully demonstrated. Here, we show that EphA2 was upregulated in glio
Externí odkaz:
https://doaj.org/article/ed413f5130e149ddbaca7dafe40c48fd
Autor:
Hao Duan, Ji-Long Hu, Zheng-He Chen, Jue-Hui Li, Zhen-Qiang He, Zhen-Ning Wang, Guan-Hua Zhang, Xiao-Yu Guo, Lun Liang, Yong-Gao Mou, Li-Shao Guo
Publikováno v:
Chinese Medical Journal, Vol 133, Iss 12, Pp 1415-1421 (2020)
Abstract. Background. Cerebrospinal fluid (CSF) has been demonstrated as a better source of circulating tumor DNA (ctDNA) than plasma for brain tumors. However, it is unclear whether whole exome sequencing (WES) is qualified for detection of ctDNA in
Externí odkaz:
https://doaj.org/article/14317b13aaa1412ca12c65b5ecb49d50
Autor:
Xiao-Yu Guo, Sheng Zhong, Zhen-Ning Wang, Tian Xie, Hao Duan, Jia-Yu Zhang, Guan-Hua Zhang, Lun Liang, Run Cui, Hong-Rong Hu, Jie Lu, Yi Wu, Jia-Jun Dong, Zhen-Qiang He, Yong-Gao Mou
Publikováno v:
Frontiers in Genetics, Vol 12 (2021)
Enhancer RNAs, a type of long non-coding RNAs (lncRNAs), play a critical role in the occurrence and development of glioma. RNA-seq data from 161 glioblastoma multiforme (GBM) samples were acquired from The Cancer Genome Atlas database. Then, 70 eRNAs
Externí odkaz:
https://doaj.org/article/206e509950db4931af14d95b395c0326
Autor:
Zheng-he Chen, Xiang-heng Zhang, Fu-hua Lin, Chang Li, Jie-tian Jin, Zhi-huan Zhou, Si-han Zhu, Zhu-qing Cheng, Sheng Zhong, Zhen-qiang He, Hao Duan, Xia Wen, Jian Wang, Yong-gao Mou
Publikováno v:
Journal of Neuro-Oncology. 158:463-470
Introduction Surgical resection of medulloblastoma (MB) remains a challenge. At present, a variety of tracers have been used for intraoperative tumor visualization. However, there are few reports on the intraoperative visualization of MB. Hence, we r
Autor:
Sheng Zhong, Jia-Xin Ren, Ze-Peng Yu, Yi-Da Peng, Cheng-Wei Yu, Davy Deng, YangYiran Xie, Zhen-Qiang He, Hao Duan, Bo Wu, Hui Li, Wen-Zhuo Yang, Yang Bai, Ke Sai, Yin-Sheng Chen, Cheng-Cheng Guo, De-Pei Li, Ye Cheng, Xiang-Heng Zhang, Yong-Gao Mou
Publikováno v:
Journal of Neurosurgery; Aug2023, Vol. 139 Issue 2, p305-314, 10p
Autor:
Sheng Zhong, Jia-Xin Ren, Ze-Peng Yu, Yi-Da Peng, Cheng-Wei Yu, Davy Deng, YangYiran Xie, Zhen-Qiang He, Hao Duan, Bo Wu, Hui Li, Wen-Zhuo Yang, Yang Bai, Ke Sai, Yin-Sheng Chen, Cheng-Cheng Guo, De-Pei Li, Ye Cheng, Xiang-Heng Zhang, Yong-Gao Mou
Publikováno v:
Journal of neurosurgery.
OBJECTIVE The aim of this study was to build a convolutional neural network (CNN)–based prediction model of glioblastoma (GBM) molecular subtype diagnosis and prognosis with multimodal features. METHODS In total, 222 GBM patients were included in t
Publikováno v:
WFNOS 2022 Abstract Book.
Autor:
Zhen-ning Wang, Xiao-bing Jiang, Jie Lu, Xiao-yu Guo, Zhen-qiang He, Hao Duan, Lun Liang, Run Cui, Hong-rong Hu, Xiang-heng Zhang, Sheng Zhong, Chang Li, Cheng-wei Yu, Cheng-cheng Guo, Yong-gao Mou
Publikováno v:
Annals of surgical oncology. 29(6)
Brain metastases (BMs) are the most serious complication of lung cancer, affecting the prognosis of lung cancer patients, and pose distinct clinical challenges. This study was designed to explore the prognostic factors related to lung cancer BM and t
Publikováno v:
Journal of Clinical Oncology. 40:e14014-e14014
e14014 Background: Nearly all patients (pts) with glioblastoma (GBM) will suffered relapse or disease progression after resection and adjuvant radiotherapy and temozolomide (TMZ). Anlotinib is a new multikinase inhibitors (MKI) blocking angiogenesis
Autor:
Cheng cheng Guo, Hao Duan, Zhongping Chen, Yong Gao Mou, Zhen Qiang He, Xiao Bing Jiang, Jian Wang, Jue Hui Li, Ke Sai, Zhe Zhu
Publikováno v:
Cancer Management and Research
Hao Duan,1,* Zhen-Qiang He,1,* Cheng-Cheng Guo,1 Jue-Hui Li,1 Jian Wang,1 Zhe Zhu,2 Ke Sai,1 Zhong-Ping Chen,1 Xiao-Bing Jiang,1 Yong-Gao Mou1 1Department of Neurosurgery/Neuro-Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of O